Showing metabocard for N-Acetyl-L-aspartic acid (MMDBc0000550)

Record Information
Version1.0
StatusDetected and Quantified
Creation Date2020-12-10 18:40:19 UTC
Update Date2024-10-09 19:40:37 UTC
Metabolite IDMMDBc0000550
Metabolite Identification
Common NameN-Acetyl-L-aspartic acid
DescriptionN-Acetyl-L-Aspartic acid (NAA) or N-Acetylaspartic acid, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-alpha-Acetyl-L-aspartic acid can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetyl-L-aspartic acid is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-aspartic acid. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618 ). About 85% of all human proteins and 68% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686 ). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468 ). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468 ). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetylaspartate can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618 ). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free aspartic acid can also occur. In particular, N-Acetyl-L-aspartic acid can be synthesized in neurons from the amino acid aspartate and acetyl coenzyme A (acetyl CoA). Specifically, the enzyme known as aspartate N-acetyltransferase (EC 2.3.1.17) catalyzes the transfer of the acetyl group of acetyl CoA to the amino group of aspartate. N-Acetyl-L-aspartic acid is the second most concentrated molecule in the brain after the amino acid glutamate. The various functions served by N-acetylaspartic acid are still under investigation, but the primary proposed functions include (1) acting as a neuronal osmolyte that is involved in fluid balance in the brain, (2) serving as a source of acetate for lipid and myelin synthesis in oligodendrocytes (the glial cells that myelinate neuronal axons), (3) serving as a precursor for the synthesis of the important dipeptide neurotransmitter N-acetylaspartylglutamate (NAAG), and (4) playing a potential role in energy production from the amino acid glutamate in neuronal mitochondria. High neurotransmitter (i.e. N-acetylaspartic acid) levels can lead to abnormal neural signaling, delayed or arrested intellectual development, and difficulties with general motor skills. When present in sufficiently high levels, N-acetylaspartic acid can be a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural tissue. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of N-acetylaspartic acid are associated with Canavan disease. Because N-acetylaspartic acid functions as an organic acid and high levels of organic acids can lead to a condition known as acidosis. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. Infants with acidosis have symptoms that include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, seizures, coma, and possibly death. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and flapping tremors. Many N-acetylamino acids, including N-acetylaspartic acid, are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986 ; PMID: 20613759 ). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557 ).
Structure
MOLSDFPDBSMILESInChI

MOL for #<Metabolite:0x00007f46695cb848>

Download
3D MOL for #<Metabolite:0x00007f46695cb848>
Download
3D SDF for #<Metabolite:0x00007f46695cb848>
Download
3D-SDF for #<Metabolite:0x00007f46695cb848>
Download
PDB for #<Metabolite:0x00007f46695cb848>
Download
3D PDB for #<Metabolite:0x00007f46695cb848>
Download
SMILES for #<Metabolite:0x00007f46695cb848>
Download
INCHI for #<Metabolite:0x00007f46695cb848>
Download
Synonyms
ValueSource
(S)-2-(Acetylamino)butanedioic acidChEBI
(S)-2-(Acetylamino)succinic acidChEBI
Acetyl-L-aspartic acidChEBI
Acetylaspartic acidChEBI
L-N-Acetylaspartic acidChEBI
N-Acetylaspartic acidChEBI
NAAChEBI
(S)-2-(Acetylamino)butanedioateGenerator
(S)-2-(Acetylamino)succinateGenerator
Acetyl-L-aspartateGenerator
AcetylaspartateGenerator
L-N-AcetylaspartateGenerator
N-AcetylaspartateGenerator
N-Acetyl-L-aspartateGenerator
(2S)-2-AcetamidobutanedioateHMDB
(2S)-2-Acetamidobutanedioic acidHMDB
N-Acetyl-S-aspartateHMDB
N-Acetyl-S-aspartic acidHMDB
N-Acetyl aspartateHMDB
N-Acetylaspartate, monopotassium saltHMDB
Acetyl aspartic acidHMDB
Molecular FormulaC6H9NO5
Average Mass175.1394
Monoisotopic Mass175.048072403
IUPAC NameNot Available
Traditional NameNot Available
CAS Registry NumberNot Available
SMILESNot Available
InChI Identifier
InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1
InChI KeyOTCCIMWXFLJLIA-BYPYZUCNSA-N